DELHI: Nepal has received one million Covishield vaccines on Sunday, from India. Covishield vaccine arrived at the Tribhuvan International Airport in the capital city of Kathmandu.
The second shipment of the Oxford-AstraZeneca vaccine, manufactured by Serum Institute of India (SII) based in Pune, which has collaborated with Oxford University and pharmaceutical company.
Official Twitter page of the Embassy of India Kathmandu has tweeted “1 million doses of #MadeInIndia Covid19 vaccine purchased by Government of Nepal arrived today at Tribhuvan International Airport, Kathmandu. It will contribute to sustaining Nepal’s ongoing nation-wide vaccination drive.”
1 million doses of #MadeInIndia Covid19 vaccine purchased by Government of Nepal arrived today at Tribhuvan International Airport, Kathmandu. It will contribute to sustaining Nepal’s ongoing nation-wide vaccination drive. #VaccineMaitri@MEAIndia@PMOIndia@mohpnep pic.twitter.com/cIZ6sjub0s
— IndiaInNepal (@IndiaInNepal) February 21, 2021
Earlier, India had provided one million doses of the Covishield vaccine as ‘gift’ (free of cost) to the Himalayan nation in January. The campaign actually aims to immunize 72 per cent of its total population of over 29 million. The government is now working towards administering doses to those above the age of 55 from March.
Nepal has recorded 2,73,431 cases of Covid-19 till now out of which 2,061 people have died while nearly 270,000 have recovered, according to worldometers.info figures.
So far, the country had provided vaccines to many countries till now and would extend supplies to more countries in the near future that would range from Europe, Latin America and the Caribbean to Africa, South-East Asia and the Pacific Islands.
India is also one of the World’s biggest drug makers and an increasing number of countries that have already approached it for obtaining the coronavirus vaccines.
Support our brand of fearless and investigative journalism: